
What is the PSA test? - Cancer Research UK
May 14, 2025 · The PSA test is a blood test that measures the amount of prostate specific antigen (PSA) in your blood. It can help to diagnose prostate cancer.
Prostate Specific Antigen (PSA) Testing | Cancer Research UK
The role of the prostate specific antigen (PSA) test in investigating cancer and guidance for GPs in using the PSA as a first-line investigation.
Treatment if your prostate cancer comes back - Cancer Research UK
Treatment if your prostate cancer comes back Your prostate cancer might come back after having treatment to try to cure it. If this happens it is called recurrent or relapsed prostate cancer.
Grade Groups for prostate cancer - Cancer Research UK
If your cancer has not spread, the doctor combines your Grade Group, PSA and TNM stage. They put your cancer into one of the 5 Cambridge Prognostic Groups (CPGs). Find out more about prostate …
TNM staging for prostate cancer - Cancer Research UK
The TNM staging system is a way that doctors stage prostate cancer. It stands for Tumour, Node, Metastasis. It tells you how far the prostate cancer has spread.
A trial looking at a PSA blood test for prostate cancer (CAP trial)
Jan 7, 2002 · This trial was done to see if an invitation to have a PSA blood test would reduce the number of men dying from prostate cancer.
Stages, types and grades of prostate cancer - Cancer Research UK
May 15, 2025 · Stages, types and grades of prostate cancer Stage means the size of the cancer and whether it has spread. The grade looks at how abnormal the cells look under a microscope. The type …
NICE (NG12) Suspected Cancer: Recognition & Referral guidelines
Apr 8, 2025 · Download our free resources below that summarise the NICE NG12 guidelines to support you with recognising and referring suspected cancer.
Hormone therapy for metastatic prostate cancer - Cancer Research UK
You might have hormone therapy for prostate cancer that has spread to another part of your body. You can have it as an injection or tablets.
Cambridge prognostic groups and risk groups for prostate cancer
Doctors group prostate cancer into risk groups. In the UK, they now use the Cambridge Prognostic Group (CPG) system that divides prostate cancer into 5 risk groups.